Results: 4

TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy

ABSTRACT Objective Thyrotoxicosis is established risk factor for osteoporosis due to increased bone turnover. Glucocorticoids often administered for Graves' orbitopathy (GO) have additional negative effect on bone mineral density (BMD). Our aim was to examine the influence of thyroid hormones, TSH, TSH-...

Autoimmune and non-autoimmune thyroid diseases have different patterns of cellular HLA class II expression

Säo Paulo med. j; 117 (4), 1999
CONTEXT: Surface HLA-DR antigen is usually only expressed by antigen-presenting cells (APC). In autoimmune thyroid disease, follicle cells function as APC, thus expressing HLA-DR. However, non-autoimmune thyroid diseases may also express surface class II antigens. OBJECTIVE: To evaluate the presence and ...

Orbitopatía tiroidea. Primera parte
Thyroid orbitopathy. First part

Rev. mex. oftalmol; 73 (3), 1999
Se hace una revisión bibliográfica de las principales características de la orbitopatía tiroidea y se menciona la experiencia de nuestro servicio...